Skip to content
10-K

Annual Report

Evolutionary Genomics, Inc.

0001553350-19-000304

← back to feed
Filed
Apr 1, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Dec 31, 2018 5.88M sh
Operating Cash Flow FY 2018 · Dec 31, 2017 −$1.18M
Short Term Investments FY 2018 · Dec 31, 2017 $290.71K
Current Liabilities FY 2018 · Dec 31, 2017 $10.64K
Total Liabilities FY 2018 · Dec 31, 2017 $966.09K
Current Assets FY 2018 · Dec 31, 2017 $1.19M
Total Assets FY 2018 · Dec 31, 2017 $5.4M
Sga Expense FY 2018 · Dec 31, 2017 $271.36K
Rd Expense FY 2018 · Dec 31, 2017 $791.06K
Net Income FY 2018 · Dec 31, 2017 −$539.62K
Operating Income FY 2018 · Dec 31, 2017 −$1.3M
Revenue FY 2018 · Dec 31, 2017 $32.69K
Cash And Equivalents FY 2018 · Dec 31, 2016 $2.06M
Stockholders Equity FY 2018 · Dec 31, 2016 $1.84M